Endocrinology

Top Story

Epigenetic modifications may increase obesity risk

May 27, 2017

Researchers have identified a possible association between epigenetic modifications, which control the activity of genes, and increased obesity risk, according to a press release.

Karen Lillycrop, professor of epigenetics at the University of Southampton, U.K., and colleagues examined DNA methylation — a key epigenetic modification that contributes to embryonic development and the formation of different cell types by regulating when and where genes are switched on — in umbilical cord tissue of babies participating in the Southampton Women’s Survey as part of the EpiGen Global Consortium.

In the Journals Plus

Obesity, diabetes associated with increased risk for severe malaria infection

May 27, 2017
Comorbidity, particularly diabetes, and obesity were significant risk factors for severe infection among nonimmune travelers and immigrants from endemic countries in…
In the Journals Plus

Low 25-(OH)D levels tied to poor glycemic control, more insulin use

May 26, 2017
In adults with type 2 diabetes and chronic kidney disease, lower vs. higher levels of serum 25-hydroxyvitamin D were associated with poorer glycemic control and use of…

Phase 3 data for Romosozumab were favorable for postmenopausal women with osteoporosis

May 26, 2017
Romosozumab met both primary endpoints in the ARCH phase 3 study of postmenopausal women with osteoporosis, according to a company release. “The efficacy results…
In the Journals Plus

High DHEAS increases early puberty risk in girls

May 26, 2017
Girls with high dehydroepiandrosterone sulfate levels had an increased risk for early therlarche and early pubarche, whereas high dehydroepiandrosterone sulfate levels…
More News Headlines »
CME

Rapid Response from Austin: Expanding Options in Type 2 Diabetes Management

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Approximately 150 million people worldwide have diabetes mellitus and this number is expected to double by 2025…
More »
Video
Meeting News

VIDEO: Joint session offers thyroid surgeons’ insights into thyroidectomy

April 6, 2017
More »
Featured
The Endocrine Society Annual Meeting

The Endocrine Society Annual Meeting

CNE CME CPE

What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Lipid Association.

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia and…
More »
Current Issues
View the Current Issue
Advertisement
Advertisement